Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
01/04/202413:00GlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
20/03/202411:30GlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
27/02/202413:00GlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
14/02/202412:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
30/01/202413:00GlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
24/01/202413:00GlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
11/12/202318:00GlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
05/12/202312:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/12/202312:30GlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
27/11/202312:30GlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
08/11/202322:00GlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
12/10/202313:02GlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
16/06/202321:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
30/05/202322:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
10/05/202321:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
28/04/202313:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
26/04/202321:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
25/04/202311:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
03/04/202322:29Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/04/202312:53Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
31/03/202314:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/02/202322:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
06/01/202321:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/11/202221:45Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
12/09/202222:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS